Fermenta Biotech Limited (NSE:FERMENTA)

Market Cap	13.82B +40.4%
Revenue (ttm)	5.11B -3.2%
Net Income	596.69M -42.9%
EPS	20.39 -43.0%
Shares Out	n/a
PE Ratio	23.17
Forward PE	n/a
Dividend	3.75 (0.72%)
Ex-Dividend Date	Aug 5, 2026

Volume	54,275
Open	476.30
Previous Close	480.70
Day's Range	476.00 - 505.80
52-Week Range	248.85 - 580.45
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, engages in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products in India, Europe, the United States, and internationally. It operates through Chemicals/Bulk Drug and Property segments. The company offers vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for injectables, soft gel capsules, premixes, food and beverage fortification applications; and vitamin K1, vitam...

• Industry: Pharmaceutical Preparations
• Founded: 1951
• Employees: 630
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: FERMENTA

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.25 billion, an increase of 11.92% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 9, 2026

Data Sources Report a data error